Efficacy of Posttransplant Ledipasvir-Sofosbuvir in the Treatment of Patients Who Have Undergone Chronic Hepatitis C-Related Liver Transplant.

CONCLUSIONS: With its reliability and high success rate, the ledipasvir-sofosbuvir combination is a strongly preferable treatment for patients who have undergone liver transplant due to chronic hepatitis C virus-related cirrhosis and who have virus recurrence posttransplant.
PMID: 32039667 [PubMed - as supplied by publisher]

Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - February 6, 2020 Category: Transplant Surgery Authors: Kandemir MH, Aladag M, Cagin YF, Yildirim HE, Sarici A Tags: Exp Clin Transplant Source Type: research